Chondroblast differentiation

Chondroblast differentiation is the biological process by which mesenchymal stem cells commit to a chondrogenic lineage, eventually forming chondrocytes that produce the cartilaginous extracellular matrix. This process is essential for skeletal development, particularly during endochondral ossification, and is vital for the repair of articular cartilage (PubMed: 28215550). The differentiation sequence is primarily governed by the transcription factor SOX9, which is activated by signaling pathways including TGF-beta and BMP (UniProt: P48436). Dysregulation of this process is central to the pathogenesis of osteoarthritis, where chondrocytes may undergo terminal differentiation or apoptosis, leading to matrix degradation (StatPearls: NBK541070). Therapeutic interventions often target this process using growth factors like BMP-2 to stimulate cartilage repair or in the context of tissue engineering (PubMed: 30107431). However, a major challenge in targeting this process is preventing hypertrophic differentiation, which can lead to undesirable calcification and bone formation instead of functional hyaline cartilage.

Other names

ChondrogenesisCartilage differentiationMesenchymal-to-chondrocyte transition

Stimulation of chondrogenic signaling pathways to induce the expression of cartilage-specific genes and the master transcription factor SOX9.